For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251222:nRSV3772Ma&default-theme=true
RNS Number : 3772M Duke Capital Limited 22 December 2025
22 December 2025
Duke Capital Limited
("Duke Capital", "Duke" or the "Company")
Follow-On Investment into Tristone Healthcare Limited
Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital
solutions for SME business owners in Europe and North America, is pleased to
announce a follow-on investment of £3.0 million into its existing capital
partner, Tristone Healthcare Limited ("Tristone"). This investment will enable
Duke to become the majority shareholder in Tristone, moving from 28.4%
ownership currently to 51.0% post-deal, as well as assist in the funding of
future deferred consideration payments relating to prior bolt-on acquisitions.
Tristone provides specialist residential, nursing and domiciliary care and
support in two end markets: i) high acuity adults with severe mental, physical
or learning disabilities; and ii) children and young people who require care,
support and specialist education.
Highlights:
· This investment into Tristone provides the business with ample
liquidity, ensuring that all outstanding future deferred consideration
payments can be paid in full
· The investment reflects Duke's confidence in management's
ability to continue to execute and grow the platform. Tristone management have
grown the residential capacity of the business from 200 to over 250 over the
last two years, which has subsequently led to Tristone continuously achieving
record revenue months
· £2.5 million of Duke's additional funds will be invested as
additional credit financing in Tristone, bringing the total credit financing
amount to £24.3 million
· The investment terms are the same as Duke's initial investment
into Tristone, including a yield of 13.5%
· The balance of funds will be invested as equity and used to
acquire a further 22.6% stake in Tristone, bringing Duke's total equity
ownership from 28.4% currently to a 51.0% majority stake post-deal
Neil Johnson, CEO of Duke Capital, said:
"Duke is excited to support Tristone via an additional £3.0m investment,
increasing our stake in the business to 51.0% post-deal, and setting up the
platform for continued growth in the years to come. The funding creates a
stable base to allow Tristone to focus on increasing the number of service
users it caters for, as well as ensuring the highest quality of care across
the group."
Duke Capital Portfolio
A full list of Duke's current partners is included for reference on the
Partners page of the Company's website: www.dukecapital.com/partners
(http://www.dukecapital.com/partners) .
***ENDS***
For further information, please visit https://dukecapital.com/
(https://dukecapital.com/) or contact:
Duke Capital Limited Neil Johnson / Charles Cannon Brookes / Hugo Evans +44 (0) 1481 231 816
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) Stephen Keys / Callum Davidson / Michael Johnson +44 (0) 207 220 0500
Canaccord Genuity Limited Adam James / Harry Rees +44 (0) 207 523 8000
(Joint Broker)
SEC Newgate (Financial Communications) Robin Tozer / Alice Cho / Gwen Samuel + +44 (0) 20 3757 6882 dukecapital@secnewgate.co.uk
About Duke Capital
Duke is a leading provider of hybrid capital solutions for SME business owners
in Europe and North America, combining the best features of both equity and
debt.
Since 2017, Duke has provided unique long-term financing which eliminates
re-financing risk and necessity for a short-term exit by providing a unique
'corporate mortgage' while also aligning its returns to grow with the success
of the business.
Duke is focused on generating attractive risk-adjusted returns for
shareholders and has a track record of achieving this across market cycles.
It's three investment pillars are capital preservation, attractive dividend
yield, and to provide upside upon exits.
Duke is listed on the AIM market under the ticker DUKE and is headquartered in
Guernsey.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUAAWRVWUUUAA
Copyright 2019 Regulatory News Service, all rights reserved